To Remember the Importance of both Donor Choice and HLA Matching to Reduce Morbidity and Mortality after Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
*Corresponding Author
:
Dr. Marie Detrait, Hematology Department, CHRU Nancy, Hôpitaux de Brabois, Nancy, France, Tel: 33383154377, Email: detraitmarie@gmail.com
Received Date: Sep 15, 2021 / Accepted Date: Sep 29, 2021 / Published Date: Oct 05, 2021
Keywords: Hematopoietic Stem Cell Transplant (HSCT)
Citation: Detrait M (2021) To Remember the Importance of both Donor Choice and HLA Matching to Reduce Morbidity and Mortality after Allogeneic Hematopoietic Stem Cell Transplant (HSCT) J Oncol Res Treat 6:168. Doi: 10.4172/aot.1000168
Copyright: © 2021 Detrait M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 1426
- [From(publication date): 0-2021 - Sep 18, 2024]
- Breakdown by view type
- HTML page views: 1032
- PDF downloads: 394
